The effect of microRNA-124 overexpression on anti-tumor drug sensitivity

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Chen, Shiau Mei ^a,b   Chou, Wen Cheng ^b   Hu, Ling Yueh ^b   Hsiung, Chia Ni ^b   Chu, Hou Wei ^b   Huang, Yuan Ling ^a,b   Hsu, Huan Ming ^c   Yu, Jyh Cherng ^c   Shen, Chen Yang ^a,b,d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MESSENGER RNA; MICRORNA 124; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT; ATMIN PROTEIN, HUMAN; MICRORNA; MIRN124 MICRORNA, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ARTICLE; ATM INTERACTOR GENE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOWN REGULATION; DRUG SENSITIVITY; GENE; GENE EXPRESSION; HOMOLOGOUS RECOMBINATION; HUMAN; MAJOR CLINICAL STUDY; OSTEOSARCOMA CELL LINE; OVERALL SURVIVAL; POLY (ADP RIBOSE) POLYMERASE 1 GENE; BREAST TUMOR; DNA REPAIR; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MORTALITY; NEOPLASMS; OSTEOSARCOMA; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; OSTEOSARCOMA; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASES; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84938630523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128472     Document Type: Article

References (48)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. PMID: 14744438.
2. Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011; 38(6):724-33. Epub 2011/11/16. doi: 10.1053/j.seminoncol.2011.08.006 PMID: 22082758.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-66. doi: 10.1038/nrc1997 PMID: 17060945.
4. Greene SB, Herschkowitz JI, Rosen JM. Small players with big roles: microRNAs as targets to inhibit breast cancer progression. Curr Drug Targets. 2010; 11(9):1059-73. PMID: 20545613; PubMed Central PMCID: PMC3006232.
5. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell. 2007; 27(3):435-48. doi: 10.1016/j.molcel.2007.07.015 PMID: 17679093; PubMed Central PMCID: PMC3139456.
6. Pierson J, Hostager B, Fan R, Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol. 2008; 90(1):1-7. doi: 10.1007/s11060-008-9624-3 PMID: 18607543.
7. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008; 6:14. doi: 10.1186/1741-7015-6-14 PMID: 18577219; PubMed Central PMCID: PMC2443372.
8. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011; 147(6):1233-47. Epub 2011/12/14. doi: 10.1016/j.cell.2011.10.043 PMID: 22153071; PubMed Central PMCID: PMC3251960.
9. Hunt S, Jones AV, Hinsley EE, Whawell SA, Lambert DW. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett. 2011; 585(1):187-92. doi: 10.1016/j.febslet.2010.11.038 PMID: 21112327.
10. Lang Q, Ling C. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem Biophys Research Commun. 2012; 426(2):247-52. doi: 10.1016/j.bbrc.2012.08.075 PMID: 22940133.
11. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut. 2012; 61(2):278-89. Epub 2011/06/16. doi: 10.1136/gut.2011.239145 PMID: 21672940.
12. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, et al. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis. 2013; 34(3):713-22. doi: 10.1093/carcin/bgs383 PMID: 23250910; PubMed Central PMCID: PMC3581604.
13. Wong KY, So CC, Loong F, Chung LP, Lam WW, Liang R, et al. Epigenetic inactivation of the miR-124-1 in haematological malignancies. PloS One. 2011; 6(4):e19027. doi: 10.1371/journal.pone.0019027 PMID: 21544199; PubMed Central PMCID: PMC3081325.
14. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007; 67(4):1424-9. doi: 10.1158/0008-5472.CAN-06-4218 PMID: 17308079.
15. Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer. 2010; 9:167. doi: 10.1186/1476-4598-9-167 PMID: 20579385; PubMed Central PMCID: PMC2917428.
16. Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN, et al. A novel estrogen receptormicroRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Hum Mol Genet. 2014; 23(2):355-67. doi: 10.1093/hmg/ddt426 PMID: 24009311.
17. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014; 64(1):52-62. doi: 10.3322/caac.21203 PMID: 24114568.
18. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010; 363(20):1938-48. doi: 10.1056/NEJMra1001389 PMID: 21067385.
19. Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res. 2009; 152:15-32. doi: 10.1007/978-1-4419-0284-9-2 PMID: 20213384.
20. Moore DD, Luu HH. Osteosarcoma. Cancer Treat Res. 2014; 162:65-92. doi: 10.1007/978-3-319-07323-1-4 PMID: 25070231.
21. Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008; 8(3):193-204. Epub 2008/02/08. doi: 10.1038/nrc2342 PMID: 18256616.
22. Curtin NJ, Wang LZ, Yiakouvaki A, Kyle S, Arris CA, Canan-Koch S, et al. Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. Clin Cancer Res. 2004; 10(3):881-9. PMID: 14871963.
23. Smith LM, Willmore E, Austin CA, Curtin NJ. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Clin Cancer Res. 2005; 11(23):8449-57. doi: 10.1158/1078-0432.CCR-05-1224 PMID: 16322308.
24. Kanu N, Behrens A. ATMIN defines an NBS1-independent pathway of ATM signalling. EMBO J. 2007; 26(12):2933-41. doi: 10.1038/sj.emboj.7601733 PMID: 17525732; PubMed Central PMCID: PMC1894771.
25. Kanu N, Behrens A. ATMINistrating ATM signalling: regulation of ATM by ATMIN. Cell Cycle. 2008; 7(22):3483-6. PMID: 19001856.
26. Zhang T, Penicud K, Bruhn C, Loizou JI, Kanu N, Wang ZQ, et al. Competition between NBS1 and ATMIN controls ATM signaling pathway choice. Cell Rep. 2012; 2(6):1498-504. doi: 10.1016/j.celrep.2012.11.002 PMID: 23219553.
27. Loizou JI, Sancho R, Kanu N, Bolland DJ, Yang F, Rada C, et al. ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma. Cancer Cell. 2011; 19(5):587-600. Epub 2011/05/18. doi: 10.1016/j.ccr.2011.03.022 PMID: 21575860.
28. Hsiung C, Chu H, Huang Y, Chou W, Hu L, Hsu H, et al. Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements. Breast Cancer Res. 2014; 16(5):455. doi: 10.1186/s13058-014-0455-1 PMID: 25298020.
29. Chou WC, Wang HC, Wong FH, Ding SL, Wu PE, Shieh SY, et al. Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. EMBO Journal. 2008; 27(23):3140-50. doi: 10.1038/emboj.2008.229 PMID: 18971944; PubMed Central PMCID: PMC2599873.
30. Liang Y, Lin SY, Brunicardi FC, Goss J, Li K. DNA damage response pathways in tumor suppression and cancer treatment. World J Surg. 2009; 33(4):661-6. doi: 10.1007/s00268-008-9840-1 PMID: 19034564.
31. Rastelli F, Biancanelli S, Falzetta A, Martignetti A, Casi C, Bascioni R, et al. Triple-negative breast cancer: current state of the art. Tumori. 2010; 96(6):875-88. PMID: 21388048.
32. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. doi: 10.1038/ng1536 PMID: 15806104.
33. Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH. A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA. 2008; 14(11):2290-6. doi: 10.1261/rna.1188208 PMID: 18812437; PubMed Central PMCID: PMC2578856.
34. Gusev Y. Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods. 2008; 44(1):61-72. doi: 10.1016/j.ymeth.2007.10.005 PMID: 18158134.
35. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 1999; 13(20):2633-8. PMID: 10541549; PubMed Central PMCID: PMC317094.
36. Papatheodorou I, Crichton C, Morris L, Maccallum P, Group M, Davies J, et al. A metadata approach for clinical data management in translational genomics studies in breast cancer. BMC Med Genomics. 2009; 2:66. doi: 10.1186/1755-8794-2-66 PMID: 19948017; PubMed Central PMCID: PMC3225860.
37. Wang P, Chen L, Zhang J, Chen H, Fan J, Wang K, et al. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene. 2014; 33(4):514-24. doi: 10.1038/onc.2012.598 PMID: 23334332.
38. Curtin NJ, Szabo C. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol Aspects Med. 2013; 34(6):1217-56. doi: 10.1016/j.mam.2013.01.006 PMID: 23370117; PubMed Central PMCID: PMC3657315.
39. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10(6):515-27. doi: 10.1016/j.ccr.2006.10.008 PMID: 17157791; PubMed Central PMCID: PMC2730521.
40. Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics. 2013; 29(5):638-44. doi: 10.1093/bioinformatics/btt014 PMID: 23325619.
41. Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y, et al. MicroRNA-124 Suppresses Breast Cancer Cell Growth and Motility by Targeting CD151. Cell Physiol Biochem. 2013; 31(6):823-32. doi: 10.1159/000350100 PMID: 23816858.
42. Lv Z, Yang L. miR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Mol Med Rep. 2013; 8(2):345-9. doi: 10.3892/mmr.2013.1561 PMID: 23817964.
43. McNees CJ, Conlan LA, Tenis N, Heierhorst J. ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage. EMBO J. 2005; 24(13):2447-57. doi: 10.1038/sj.emboj.7600704 PMID: 15933716; PubMed Central PMCID: PMC1173145.
44. Oka H, Sakai W, Sonoda E, Nakamura J, Asagoshi K, Wilson SH, et al. DNA damage response protein ASCIZ links base excision repair with immunoglobulin gene conversion. Biochem Biophys Res Commun. 2008; 371(2):225-9. doi: 10.1016/j.bbrc.2008.04.052 PMID: 18433721.
45. Zhang T, Cronshaw J, Kanu N, Snijders AP, Behrens A. UBR5-mediated ubiquitination of ATMIN is required for ionizing radiation-induced ATM signaling and function. Proc Natl Acad Sci U S A. 2014;111(33):12091-6. doi: 10.1073/pnas.1400230111 PMID: 25092319; PubMed Central PMCID: PMC4143036.
46. Caldecott KW. XRCC1 and DNA strand break repair. DNA repair. 2003; 2(9):955-69. PMID: 12967653.
47. Fisher AE, Hochegger H, Takeda S, Caldecott KW. Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase. Mol Cell Biol. 2007; 27(15):5597-605. doi: 10.1128/MCB.02248-06 PMID: 17548475; PubMed Central PMCID: PMC1952076.
48. Manakov SA, Morton A, Enright AJ, Grant SG. A Neuronal Transcriptome Response Involving Stress Pathways is Buffered by Neuronal microRNAs. Front Neurosci. 2012; 6:156. doi: 10.3389/fnins.2012.00156 PMID: 23115547; PubMed Central PMCID: PMC3483788.